HUMA · Humacyte Inc
United States · RS rating 12 · As of 2026-11-03
| Price | 0.44 USD |
|---|---|
| 1-day change | +10.7% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 32 / 14 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 4 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -77.8% |
| Sales growth Q/Q | -38.0% |
| Distance from 52-week high | +72.3% |
| Market cap (USD) | $157.2M |